Sign in
Taking peopleNo phase

Blood markers and long-term problems after a first leg blood clot

Studies blood markers and later complications in people with a first leg blood clot.

Key facts

Who runs it
Ove Andersen
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Deep Venous Thrombosis and Long Term Complications
Status
Recruiting
People taking part
178 people, planned
Started
14 Mar 2023
Expected to end
1 Sept 2029
Type of study
Interventional
Treatments tested
  • Blood sample and Ultrasound examination
Record updated
23 February 2026

Who can take part

The trial is looking for adults admitted to the Emergency Department with a first blood clot in a deep vein of the leg (DVT). It studies blood markers and long-term problems over 2 years.

Age
18 years or older
Sex
All sexes
Disease stage
First time deep vein blood clot (DVT) in the leg, while in the Emergency Department
Main reasons for not taking part
  • No Danish social security number
  • Patients at the end of life (terminal illness)
  • Not able to understand or speak Danish
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • 18 years or above
  • First time lower extremity DVT
  • Hospitalized at the Emergency Department

Who cannot take part

  • Patients without a Danish social security number
  • Terminal patients
  • Patients who do not understand or speak Danish

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • DVT of legs

This trial is currently available in Denmark.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this cohort study, the investigators will investigate the concentration of biomarkers, e.g., inflammatory, anti-inflammatory, immunological, senescent, biochemical ratio-calculations, blood cell type, and and long term complications with a 2-year follow-up in patients with first time lower extremity deep venous thrombosis

The group in the trial

  • Biomarkers and long term complications in DVT patientsOther group

    Patients with DVT will be enrolled in the study during their hospitalization at the ED. The enrolled patients will have 4 follow-up visits, 1) during the first 14 days after diagnosis, 2) after 3 months, 3) after 12 months and 4) 24 months after the time of diagnosis.

    Treatment: Blood sample and Ultrasound examination

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Deep Venous Thrombosis and Risk of Long Term Complications in Acutely Admitted Patients
Plain-language title
Blood markers and long-term problems after a first leg blood clotGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05789108, who can take part
Record updated
23 February 2026